Contract award record
NHS National Framework for Transition products commencing 1 October 2024
Tender value £41,320,000
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer and contract winner
Award value£16,224,000
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:
CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)
CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England